HIV-associated lymphoma: Promising new results, but with toxicity

13Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Treatment of HIV-associated non-Hodgkin lymphoma with rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide resulted in high complete remission and 2-year failure-free and overall survival rates but a high rate of infection.

Cite

CITATION STYLE

APA

Straus, D. J. (2005, March 1). HIV-associated lymphoma: Promising new results, but with toxicity. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2004-12-4729

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free